0001181431-12-002270.txt : 20120111
0001181431-12-002270.hdr.sgml : 20120111
20120111174158
ACCESSION NUMBER: 0001181431-12-002270
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120110
FILED AS OF DATE: 20120111
DATE AS OF CHANGE: 20120111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Olek Elizabeth A
CENTRAL INDEX KEY: 0001419066
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33095
FILM NUMBER: 12522781
MAIL ADDRESS:
STREET 1: C/O ACHILLION PHARMACEUTICALS, INC.
STREET 2: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070336
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-624-7000
MAIL ADDRESS:
STREET 1: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
4
1
rrd330439.xml
OLEK 01.10.12 SALE
X0304
4
2012-01-10
0
0001070336
ACHILLION PHARMACEUTICALS INC
ACHN
0001419066
Olek Elizabeth A
C/O ACHILLION PHARMACEUTICALS
300 GEORGE STREET
NEW HAVEN
CT
06511
0
1
0
0
SVP and CMO
Common Stock
2012-01-10
4
M
0
12468
3.28
A
14468
D
Common Stock
2012-01-10
4
S
0
12468
10.06
D
2000
D
Employee Stock Option (Right to Buy)
3.28
2012-01-10
4
M
0
12468
0
D
2019-12-18
Common Stock
12468
20782
D
This option was granted on December 18, 2009 and vests over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
The transactions reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by Ms. Olek on June 7, 2011.
/s/ Elizabeth A. Olek
2012-01-11